awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36561848-1CA12E4D-3D32-4205-8528-CECF4D941C38
Q36561848-1CA12E4D-3D32-4205-8528-CECF4D941C38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36561848-1CA12E4D-3D32-4205-8528-CECF4D941C38
A dose-schedule finding design for phase I-II clinical trials
P2860
Q36561848-1CA12E4D-3D32-4205-8528-CECF4D941C38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36561848-1CA12E4D-3D32-4205-8528-CECF4D941C38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d16fbc4dadfc7ed57f6834317078399d07faa7e
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).